By Aaron Nicodemus2023-09-13T20:29:00
Gary Gensler, despite being put on the spot by a member of Congress, declined to provide an update on when the Securities and Exchange Commission (SEC) might approve its climate-related disclosure rule for public companies.
When asked specifically by Sen. Tina Smith (D-Minn.) about when the controversial rule might be finalized in a hearing Tuesday before the Senate Committee on Banking, Housing, and Urban Affairs, Gensler would not offer a time line.
“I don’t want to be pinned down on this one. There is a very heavy comment file, and some really important issues have been raised,” said the SEC chair.
2024-11-21T20:09:00Z By Ian Sherr
Securities and Exchange Commission Chair Gary Gensler will step down from his position as the top U.S. regulator of Wall Street when Donald Trump is sworn in as president on Jan. 20, ending weeks of speculation about his future.
2023-12-07T17:48:00Z By Kyle Brasseur
The Securities and Exchange Commission’s latest regulatory agenda remains packed with proposals in the final rule stage, most notably the agency’s climate-related disclosure package.
2023-09-20T21:46:00Z By Adrianne Appel
There is much companies can do—and must do, given upcoming regulatory requirements—to rein in Scope 3 emissions, sustainability expert Susan McNichols discussed at CW’s virtual ESG Summit.
2025-10-15T19:43:00Z By Jaclyn Jaeger
Under the Trump administration, the Department of Health and Human Services and the Food and Drug Administration have been hellbent on eliminating synthetic food dyes from food and beverage products, forcing a jarring and costly overhaul with cascading impacts on the operations of the entire industry.
2025-10-08T20:08:00Z By Ruth Prickett
Private companies that are keen to trade their shares but do not wish to become listed have gained another way to trade their shares. The U.K. government completed its initial review and published rules for the system in June.
2025-10-03T21:24:00Z By Adrianne Appel
While the Trump administration may have shifted away from pursuing small, white-collar, financial crimes, its focus on health care fraud cases is as hot as ever.
Site powered by Webvision Cloud